rs374899270
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 1P and 0B. PM4_Supporting
The NM_138773.4(SLC25A46):c.938_940delATT(p.Tyr313del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000545 in 1,613,576 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. Y313Y) has been classified as Likely benign.
Frequency
Consequence
NM_138773.4 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- neuropathy, hereditary motor and sensory, type 6BInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), ClinGen
- pontocerebellar hypoplasia, type 1EInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- hereditary motor and sensory neuropathy type 6Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pontocerebellar hypoplasia type 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Leigh syndromeInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SLC25A46 | NM_138773.4 | c.938_940delATT | p.Tyr313del | disruptive_inframe_deletion | Exon 8 of 8 | ENST00000355943.8 | NP_620128.1 | |
| SLC25A46 | NM_001303249.3 | c.695_697delATT | p.Tyr232del | disruptive_inframe_deletion | Exon 8 of 8 | NP_001290178.1 | ||
| SLC25A46 | NM_001303250.3 | c.665_667delATT | p.Tyr222del | disruptive_inframe_deletion | Exon 8 of 8 | NP_001290179.1 | ||
| SLC25A46 | NR_138151.2 | n.1177_1179delATT | non_coding_transcript_exon_variant | Exon 9 of 9 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152024Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000319 AC: 8AN: 250482 AF XY: 0.0000443 show subpopulations
GnomAD4 exome AF: 0.0000568 AC: 83AN: 1461552Hom.: 0 AF XY: 0.0000536 AC XY: 39AN XY: 727070 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152024Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74224 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Neuropathy, hereditary motor and sensory, type 6B Uncertain:1
This variant, c.938_940del, results in the deletion of 1 amino acid(s) of the SLC25A46 protein (p.Tyr313del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs768345785, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with SLC25A46-related conditions. ClinVar contains an entry for this variant (Variation ID: 644999). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.938_940delATT variant (also known as p.Y313del) is located in coding exon 8 of the SLC25A46 gene. This variant results from an in-frame ATT deletion at nucleotide positions 938 to 940. This results in the in-frame deletion of a tyrosine at codon 313. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
SLC25A46: PM2, PM4:Supporting -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at